<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>领星GenomiCare | wechat-feeds</title><link>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</link><description>领星是由中美生物医学数据科学家携手高年资肿瘤专家共同开创的临床科技和数据平台，提供肿瘤精准医疗和数据智能服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 22 Apr 2021 13:26:39 +0800</pubDate><image><url>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</url><title>领星GenomiCare | wechat-feeds</title><link>http://MzI1NTQ2ODc0Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>一文盘点侵袭性 B 细胞淋巴瘤免疫治疗药物</title><link>https://mp.weixin.qq.com/s/k9juW0c9bm1GAsyE9Zvm_A</link><description></description><content:encoded><![CDATA[一文盘点侵袭性 B 细胞淋巴瘤免疫治疗药物]]></content:encoded><pubDate>Thu, 22 Apr 2021 11:31:44 +0800</pubDate></item><item><title>速递丨膀胱癌新型ADC药物Padcev获FDA优先审查！</title><link>https://mp.weixin.qq.com/s/J7Dky_N1KoF6tJjagkXDwQ</link><description></description><content:encoded><![CDATA[速递丨膀胱癌新型ADC药物Padcev获FDA优先审查！]]></content:encoded><pubDate>Thu, 22 Apr 2021 11:31:44 +0800</pubDate></item><item><title>临床试验丨 结直肠癌（三）</title><link>https://mp.weixin.qq.com/s/ufN1zZ5cPPdxmFpRSe-0yw</link><description></description><content:encoded><![CDATA[临床试验丨 结直肠癌（三）]]></content:encoded><pubDate>Wed, 21 Apr 2021 14:16:03 +0800</pubDate></item><item><title>可能比想象的还要难！治疗EGFR T790M突变非小细胞肺癌的最新研究解读</title><link>https://mp.weixin.qq.com/s/R_4J7wtIx1SWnIcl5Rm5gQ</link><description></description><content:encoded><![CDATA[可能比想象的还要难！治疗EGFR T790M突变非小细胞肺癌的最新研究解读]]></content:encoded><pubDate>Tue, 20 Apr 2021 11:20:39 +0800</pubDate></item><item><title>速递丨首个STING激动剂获批临床，拟开展治疗晚期实体瘤临床研究！</title><link>https://mp.weixin.qq.com/s/UaoCkjH_pxRYGxrQMV5cbg</link><description></description><content:encoded><![CDATA[速递丨首个STING激动剂获批临床，拟开展治疗晚期实体瘤临床研究！]]></content:encoded><pubDate>Tue, 20 Apr 2021 11:20:39 +0800</pubDate></item><item><title>一文盘点原发性肝癌分层筛查与监测要点</title><link>https://mp.weixin.qq.com/s/DdRcjm-I-9Sv_XewavrS5Q</link><description></description><content:encoded><![CDATA[一文盘点原发性肝癌分层筛查与监测要点]]></content:encoded><pubDate>Thu, 15 Apr 2021 17:00:58 +0800</pubDate></item><item><title>速递丨君实PD-1尿路上皮癌适应症正式获批；发现结直肠癌治疗新靶标</title><link>https://mp.weixin.qq.com/s/t7QNTbXi2hINFGiT-L30mg</link><description></description><content:encoded><![CDATA[速递丨君实PD-1尿路上皮癌适应症正式获批；发现结直肠癌治疗新靶标]]></content:encoded><pubDate>Thu, 15 Apr 2021 17:00:58 +0800</pubDate></item><item><title>星闻丨领星AACR成果速递，5项实体瘤相关研究展现科研硬实力</title><link>https://mp.weixin.qq.com/s/vGfmwL8ta4GVxuq8fIhPYg</link><description></description><content:encoded><![CDATA[星闻丨领星AACR成果速递，5项实体瘤相关研究展现科研硬实力]]></content:encoded><pubDate>Wed, 14 Apr 2021 17:19:45 +0800</pubDate></item><item><title>临床试验丨 肝癌（三）</title><link>https://mp.weixin.qq.com/s/0PxKznnDm7V5gYUpsAMvbg</link><description></description><content:encoded><![CDATA[临床试验丨 肝癌（三）]]></content:encoded><pubDate>Wed, 14 Apr 2021 17:19:45 +0800</pubDate></item><item><title>盘点丨免疫药物治疗非小细胞肺癌最新研究成果（2019-2021）</title><link>https://mp.weixin.qq.com/s/cAwfzmbsxWTsXs997H4v4g</link><description></description><content:encoded><![CDATA[盘点丨免疫药物治疗非小细胞肺癌最新研究成果（2019-2021）]]></content:encoded><pubDate>Tue, 13 Apr 2021 11:08:59 +0800</pubDate></item><item><title>速递丨阿斯利康推出下一代PARP抑制剂；人类第一个胃癌基质转录组图谱建成</title><link>https://mp.weixin.qq.com/s/CxwAGQhAaApLldPDBWsAvA</link><description></description><content:encoded><![CDATA[速递丨阿斯利康推出下一代PARP抑制剂；人类第一个胃癌基质转录组图谱建成]]></content:encoded><pubDate>Tue, 13 Apr 2021 11:08:59 +0800</pubDate></item><item><title>抗肿瘤药物怎么分类？一文为您盘点！</title><link>https://mp.weixin.qq.com/s/P1k8TYFhgD7XTyYsnJlt7A</link><description></description><content:encoded><![CDATA[抗肿瘤药物怎么分类？一文为您盘点！]]></content:encoded><pubDate>Thu, 08 Apr 2021 14:03:50 +0800</pubDate></item><item><title>速递丨重磅！科学家揭秘胶质母细胞瘤进展的具体机制</title><link>https://mp.weixin.qq.com/s/sM9NiNNdNMQ0UJ_iLJyZgg</link><description></description><content:encoded><![CDATA[速递丨重磅！科学家揭秘胶质母细胞瘤进展的具体机制]]></content:encoded><pubDate>Thu, 08 Apr 2021 14:03:50 +0800</pubDate></item><item><title>临床试验丨 肝癌（二）</title><link>https://mp.weixin.qq.com/s/UV5xNOG4R_uknxqrrtC8JA</link><description></description><content:encoded><![CDATA[临床试验丨 肝癌（二）]]></content:encoded><pubDate>Wed, 07 Apr 2021 11:09:56 +0800</pubDate></item><item><title>双免疫联合化疗一线治疗非小细胞肺癌最新研究进展</title><link>https://mp.weixin.qq.com/s/1ruklSdweB8Yp-aN2z6KUw</link><description></description><content:encoded><![CDATA[双免疫联合化疗一线治疗非小细胞肺癌最新研究进展]]></content:encoded><pubDate>Tue, 06 Apr 2021 14:25:56 +0800</pubDate></item><item><title>速递丨创新FGFR抑制剂futibatinib获FDA突破性疗法认定</title><link>https://mp.weixin.qq.com/s/EzRsVu2Y0I9Sa9DdiHSSCQ</link><description></description><content:encoded><![CDATA[速递丨创新FGFR抑制剂futibatinib获FDA突破性疗法认定]]></content:encoded><pubDate>Tue, 06 Apr 2021 14:25:56 +0800</pubDate></item><item><title>收藏丨20种常见癌症预防和筛查宝典，超有用（下）</title><link>https://mp.weixin.qq.com/s/n5HaKEnkTmMruvrRbs-YCw</link><description></description><content:encoded><![CDATA[收藏丨20种常见癌症预防和筛查宝典，超有用（下）]]></content:encoded><pubDate>Fri, 02 Apr 2021 10:50:36 +0800</pubDate></item></channel></rss>